Drug Information

Drug General Information
Drug ID
D03RQI
Former ID
DNC000617
Drug Name
ER-37328
Drug Type
Small molecular drug
Indication Discovery agent Terminated [546422]
Structure
Download
2D MOL

3D MOL
Formula
C22H22ClN3O3
Canonical SMILES
CN(C)CCC1C(=O)C2=CN=CN3C2=C(C1=O)C4=C3CCC5=C4CC=CC5=O.C<br />l
InChI
1S/C22H21N3O3.ClH/c1-24(2)9-8-14-21(27)15-10-23-11-25-16-7-6-12-13(4-3-5-17(12)26)18(16)19(20(15)25)22(14)28;/h3,5,10-11,14H,4,6-9H2,1-2H3;1H
InChIKey
WTKWSQVGFMBOGJ-UHFFFAOYSA-N
CAS Number
CAS 254751-28-5
PubChem Compound ID
21849939
PubChem Substance ID
37277027, 49890074, 103719654, 232328143
Target and Pathway
Target(s) DNA topoisomerase II Target Info Inhibitor [535624]
References
Ref 546422Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008013)
Ref 535624Antitumor activity of ER-37328, a novel carbazole topoisomerase II inhibitor. Mol Cancer Ther. 2002 Jan;1(3):169-75.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.